We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > TherapeuticsMD

News List

TherapeuticsMD Appoints Hugh O’Dowd as President firstwordpharma
August 10, 2021
TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women's healthcare company, today announced the appointment of Hugh O'Dowd as President.
Here's an SEC lesson, courtesy TherapeuticsMD: Don't tell secrets to analysts fiercepharma
August 22, 2019
Pharma companies routinely update analysts, but a Securities and Exchange Commission (SEC) punishment for tiny TherapeuticsMD might offer a lesson—or reminder—for the rest of the industry.
TherapeuticsMD Announces Commercial Availability of BIJUVA™ in the U.S. americanpharmaceuticalreview
April 18, 2019
TherapeuticsMD announced the commercial availability of BIJUVATM (estradiol and progesterone capsules, 1 mg/100 mg) in the United States.
FDA Approves Imvexxy drugs
May 31, 2018
TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women's healthcare company, today announced that the United States Food and Drug Administration (FDA) has approved Imvexxy (estradiol vaginal inserts) for the treatment of moderate-to-severe dyspareunia (